Cargando…

Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells

BACKGROUND: Casein-free, gluten-free diets have been reported to mitigate some of the inflammatory gastrointestinal and behavioral traits associated with autism, but the mechanism for this palliative effect has not been elucidated. We recently showed that the opioid peptide beta-casomorphin-7, deriv...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Malav S., Hodgson, Nathaniel W., Walker, Stephen J., Trooskens, Geert, Nair, Vineeth, Deth, Richard C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673759/
https://www.ncbi.nlm.nih.gov/pubmed/26664459
http://dx.doi.org/10.1186/s12986-015-0050-1
_version_ 1782404802233237504
author Trivedi, Malav S.
Hodgson, Nathaniel W.
Walker, Stephen J.
Trooskens, Geert
Nair, Vineeth
Deth, Richard C.
author_facet Trivedi, Malav S.
Hodgson, Nathaniel W.
Walker, Stephen J.
Trooskens, Geert
Nair, Vineeth
Deth, Richard C.
author_sort Trivedi, Malav S.
collection PubMed
description BACKGROUND: Casein-free, gluten-free diets have been reported to mitigate some of the inflammatory gastrointestinal and behavioral traits associated with autism, but the mechanism for this palliative effect has not been elucidated. We recently showed that the opioid peptide beta-casomorphin-7, derived from bovine (bBCM7) milk, decreases cysteine uptake, lowers levels of the antioxidant glutathione (GSH) and decreases the methyl donor S-adenosylmethionine (SAM) in both Caco-2 human GI epithelial cells and SH-SY5Y human neuroblastoma cells. While human breast milk can also release a similar peptide (hBCM-7), the bBCM7 and hBCM-7 vary greatly in potency; as the bBCM-7 is highly potent and similar to morphine in it's effects. Since SAM is required for DNA methylation, we wanted to further investigate the epigenetic effects of these food-derived opioid peptides. In the current study the main objective was to characterize functional pathways and key genes responding to DNA methylation effects of food-derived opioid peptides. METHODS: SH-SY5Y neuroblastoma cells were treated with 1 μM hBCM7 and bBCM7 and RNA and DNA were isolated after 4 h with or without treatment. Transcriptional changes were assessed using a microarray approach and CpG methylation status was analyzed at 450,000 CpG sites. Functional implications from both endpoints were evaluated via Ingenuity Pathway Analysis 4.0 and KEGG pathway analysis was performed to identify biological interactions between transcripts that were significantly altered at DNA methylation or transcriptional levels (p < 0.05, FDR <0.1). RESULTS: Here we show that hBCM7 and bBCM7, as well as morphine, cause epigenetic changes affecting gene pathways related to gastrointestinal disease and inflammation. These epigenetic consequences exhibited the same potency order as opiate inhibition of cysteine uptake insofar as hBCM7 was less potent than bBCM7, which was less potent than morphine. CONCLUSION: Our findings indicate that epigenetic effects of milk-derived opiate peptides may contribute to GI dysfunction and inflammation in sensitive individuals. While the current study was performed using SH-SY5Y neuronal cellular models, similar actions on other cells types might combine to cause symptoms of intolerance. These actions may provide a potential contributing mechanism for the beneficial effects of a casein-free diet in alleviating gastrointestinal symptoms in neurological conditions including autism and other conditions. Lastly, our study also contributes to the evolving awareness of a “gut-brain connection”. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12986-015-0050-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4673759
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46737592015-12-10 Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells Trivedi, Malav S. Hodgson, Nathaniel W. Walker, Stephen J. Trooskens, Geert Nair, Vineeth Deth, Richard C. Nutr Metab (Lond) Research BACKGROUND: Casein-free, gluten-free diets have been reported to mitigate some of the inflammatory gastrointestinal and behavioral traits associated with autism, but the mechanism for this palliative effect has not been elucidated. We recently showed that the opioid peptide beta-casomorphin-7, derived from bovine (bBCM7) milk, decreases cysteine uptake, lowers levels of the antioxidant glutathione (GSH) and decreases the methyl donor S-adenosylmethionine (SAM) in both Caco-2 human GI epithelial cells and SH-SY5Y human neuroblastoma cells. While human breast milk can also release a similar peptide (hBCM-7), the bBCM7 and hBCM-7 vary greatly in potency; as the bBCM-7 is highly potent and similar to morphine in it's effects. Since SAM is required for DNA methylation, we wanted to further investigate the epigenetic effects of these food-derived opioid peptides. In the current study the main objective was to characterize functional pathways and key genes responding to DNA methylation effects of food-derived opioid peptides. METHODS: SH-SY5Y neuroblastoma cells were treated with 1 μM hBCM7 and bBCM7 and RNA and DNA were isolated after 4 h with or without treatment. Transcriptional changes were assessed using a microarray approach and CpG methylation status was analyzed at 450,000 CpG sites. Functional implications from both endpoints were evaluated via Ingenuity Pathway Analysis 4.0 and KEGG pathway analysis was performed to identify biological interactions between transcripts that were significantly altered at DNA methylation or transcriptional levels (p < 0.05, FDR <0.1). RESULTS: Here we show that hBCM7 and bBCM7, as well as morphine, cause epigenetic changes affecting gene pathways related to gastrointestinal disease and inflammation. These epigenetic consequences exhibited the same potency order as opiate inhibition of cysteine uptake insofar as hBCM7 was less potent than bBCM7, which was less potent than morphine. CONCLUSION: Our findings indicate that epigenetic effects of milk-derived opiate peptides may contribute to GI dysfunction and inflammation in sensitive individuals. While the current study was performed using SH-SY5Y neuronal cellular models, similar actions on other cells types might combine to cause symptoms of intolerance. These actions may provide a potential contributing mechanism for the beneficial effects of a casein-free diet in alleviating gastrointestinal symptoms in neurological conditions including autism and other conditions. Lastly, our study also contributes to the evolving awareness of a “gut-brain connection”. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12986-015-0050-1) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-09 /pmc/articles/PMC4673759/ /pubmed/26664459 http://dx.doi.org/10.1186/s12986-015-0050-1 Text en © Trivedi et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Trivedi, Malav S.
Hodgson, Nathaniel W.
Walker, Stephen J.
Trooskens, Geert
Nair, Vineeth
Deth, Richard C.
Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells
title Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells
title_full Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells
title_fullStr Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells
title_full_unstemmed Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells
title_short Epigenetic effects of casein-derived opioid peptides in SH-SY5Y human neuroblastoma cells
title_sort epigenetic effects of casein-derived opioid peptides in sh-sy5y human neuroblastoma cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673759/
https://www.ncbi.nlm.nih.gov/pubmed/26664459
http://dx.doi.org/10.1186/s12986-015-0050-1
work_keys_str_mv AT trivedimalavs epigeneticeffectsofcaseinderivedopioidpeptidesinshsy5yhumanneuroblastomacells
AT hodgsonnathanielw epigeneticeffectsofcaseinderivedopioidpeptidesinshsy5yhumanneuroblastomacells
AT walkerstephenj epigeneticeffectsofcaseinderivedopioidpeptidesinshsy5yhumanneuroblastomacells
AT trooskensgeert epigeneticeffectsofcaseinderivedopioidpeptidesinshsy5yhumanneuroblastomacells
AT nairvineeth epigeneticeffectsofcaseinderivedopioidpeptidesinshsy5yhumanneuroblastomacells
AT dethrichardc epigeneticeffectsofcaseinderivedopioidpeptidesinshsy5yhumanneuroblastomacells